Treatment-resistant Schizophrenia Clinical Trials in Baltimore, Maryland
2 recruitingBaltimore, Maryland
Showing 1–2 of 2 trials
Recruiting
Phase 3
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
Treatment-resistant Schizophrenia
Newron Pharmaceuticals SPA400 enrolled5 locationsNCT07184619
Recruiting
Not Applicable
Deep Brain Stimulation in Treatment Resistant Schizophrenia
Treatment-resistant Schizophrenia
Johns Hopkins University6 enrolled1 locationNCT02361554